Early Life
August Troendle obtained his medical degree from the University of Maryland, School of Medicine. Before founding Medpace, Troendle's experience included working as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA from 1986 to 1987. From 1987 to 1992, he served as a manager at Sandoz (Novartis), where he was responsible for the clinical development of lipid-altering agents.
Rise to Success
In 1992, Dr. Troendle founded Medpace in Cincinnati, Ohio. His vision was to provide comprehensive support to pharmaceutical and biotechnology companies navigating clinical trials. This move capitalized on the growing need for high-quality clinical research services. He also saw an opportunity to offer a more innovative way to conduct clinical trials on behalf of biopharmaceutical sponsors.
Key Business Strategies
Dr. Troendle's leadership has been instrumental in transforming Medpace into a global powerhouse. Medpace has grown to over 6,000 associates across 40 countries, with a full-service CRO model. The company's mission is to accelerate the global development of safe and effective medical therapeutics. The company has a strong focus on a patient-centric approach.
Philanthropy
August Troendle is a compassionate philanthropist, generously supporting healthcare initiatives and research endeavors. His belief in giving back has made a lasting impact on the Cincinnati community and beyond.